The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Will the real Cowden syndrome please stand up (again)? Expanding mutational and clinical spectra of the PTEN hamartoma tumour syndrome: Table 1
Open accessAbstract
PTEN hamartoma tumour syndrome Since consensus operational diagnostic criteria for Cowden syndrome (MIM 158350) were first established in 1995, our understanding of this complex disease—and the spectrum of disorders related to it by virtue of also having germline mutations in the PTEN tumour suppressor gene—has continued to evolve. This was reflected in a commentary1 in this journal in 2000 in which it was proposed that endometrial cancer and renal cell carcinoma be added to the operational diagnostic criteria for Cowden syndrome (table 1). This updated commentary is intended to provide a review of significant changes in our understanding of the growing group of disorders, which are known to be caused by germline mutations in PTEN on 10q23.3, and which have been termed the PTEN hamartoma tumour syndrome. View this table: Table 1 International Cowden Consortium operational criteria for the diagnosis of Cowden syndrome. Ver 2000 Cowden syndrome is a complex disorder with malignant and benign (hamartomatous) lesions affecting derivatives of all three germ cell layers. Major organs involved include the breast, thyroid, uterus, brain, and mucocutaneous tissues.2 It has been estimated to affect about 1 in 200 000 individuals,3,4 although this is probably an underestimate given the difficulty in diagnosis presented by this highly variable disease and the fact that many component features in and of themselves can occur in the general population. Penetrance is related to age, with most patients presenting by their late twenties with at least the mucocutaneous lesions of this disorder, which are reportedly seen in 99% of affected individuals. The lifetime risk for breast cancer in Cowden syndrome is estimated to be 25–50%, with an average age of diagnosis between 38 and 46 years old.2,5 The risk for thyroid cancer (typically follicular, but occasionally papillary) is approximately 10%, while the risk for endometrial cancer, …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The National Comprehensive Cancer Network: Present and future directions
McGivney, W. T. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980515)82:10+<2057::aid-cncr14>3.0.co;2-a · Cited by 16,766
Liaw, D., Marsh, D. J., Li, J., Dahia, P. L. M., Wang, S. I., Zheng, Z., Bose, S., Call, K. M., Tsou, H. C., Peacoke, M., et al. (1997) · Nature Genetics · doi:10.1038/ng0597-64 · Cited by 2,091
Self-citationLohmueller, K. E., Pearce, C. L., Pike, M., Lander, E. S., & Hirschhorn, J. N. (2003) · Nature Genetics · doi:10.1038/ng1071 · Cited by 1,900
A comprehensive review of genetic association studies
Hirschhorn, J. N., Lohmueller, K., Byrne, E., & Hirschhorn, K. (2002) · Genetics in Medicine · doi:10.1097/00125817-200203000-00002 · Cited by 1,674
Problems of reporting genetic associations with complex outcomes
Colhoun, H. M., McKeigue, P. M., & Smith, G. D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12715-8 · Cited by 1,204
Ozaki, K., Ohnishi, Y., Iida, A., Sekine, A., Yamada, R., Tsunoda, T., Sato, H., Sato, H., Hori, M., Nakamura, Y., et al. (2002) · Nature Genetics · doi:10.1038/ng1047 · Cited by 952
Localization of the gene for Cowden disease to chromosome 10q22–23
Nelen, M. R., Padberg, G. W., Peeters, E. A. J., Lin, A. Y., Helm, B. V. D., Frants, R. R., Goulon, V., Goldstein, A. M., Reen, M. M. M. V., Eastern, D. F., et al. (1996) · Nature Genetics · doi:10.1038/ng0596-114 · Cited by 668
Self-citationMarsh, D. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.3.507 · Cited by 653
Prediction of the Risk of Myocardial Infarction from Polymorphisms in Candidate Genes
Yamada, Y., Izawa, H., Ichihara, S., Takatsu, F., Ishihara, H., Hirayama, H., Sone, T., Tanaka, M., & Yokota, M. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021445 · Cited by 640
Marsh, D. J., Kum, J. B., Lunetta, K. L., Bennett, M. J., Gorlin, R. J., Ahmed, S. F., Bodurtha, J., Crowe, C., Curtis, M. A., Dasouki, M., et al. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.8.1461 · Cited by 612
Self-citationWill the real Cowden syndrome please stand up: revised diagnostic criteria
Eng, C. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.11.828 · Cited by 566
Self-citationThe Cowden syndrome: a clinical and genetic study in 21 patients
Starink, T. M., Veen, J. P. W. V. D., Arwert, F., Waal, L. P. D., Lange, G. G. D., Gille, J. J. P., & Eriksson, A. W. (1986) · Clinical Genetics · doi:10.1111/j.1399-0004.1986.tb00816.x · Cited by 550
Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease
Nelen, M. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.8.1383 · Cited by 464
Proteus syndrome: Diagnostic criteria, differential diagnosis, and patient evaluation
Biesecker, L. G., Happle, R., Mulliken, J. B., Weksberg, R., Graham, J. M., Viljoen, D. L., & Cohen, M. M. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990611)84:5<389::aid-ajmg1>3.0.co;2-o · Cited by 421
Mutation of MEF2A in an Inherited Disorder with Features of Coronary Artery Disease
Wang, L., Fan, C., Topol, S. E., Topol, E. J., & Wang, Q. (2003) · Science · doi:10.1126/science.1088477 · Cited by 379
Nelen, M. R., Kremer, H., Konings, I. B., Schoute, F., Essen, A. J. V., Koch, R., Woods, C. G., Fryns, J.-P., Hamel, B., Hoefsloot, L. H., et al. (1999) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200289 · Cited by 350
A comprehensive linkage analysis for myocardial infarction and its related risk factors
Broeckel, U., Hengstenberg, C., Mayer, B., Holmer, S., Martin, L. J., Comuzzie, A. G., Blangero, J., Nürnberg, P., Reis, A., Riegger, G. A. J., et al. (2002) · Nature Genetics · doi:10.1038/ng827 · Cited by 321
Bannayan‐Riley‐Ruvalcaba syndrome
Gorlin, R. J., Cohen, M. M., Condon, L. M., & Burke, B. A. (1992) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320440309 · Cited by 315
Family history of heart attack as an independent predictor of death due to cardiovascular disease.
Barrett-Connor, E., & Khaw, K. (1984) · Circulation · doi:10.1161/01.cir.69.6.1065 · Cited by 302
Zhou, X.-P., Waite, K. A., Pilarski, R., Hampel, H., Fernandez, M. J., Bos, C., Dasouki, M., Feldman, G. L., Greenberg, L. A., Ivanovich, J., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/377109 · Cited by 285
Self-citationFrancke, S. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.24.2751 · Cited by 265
Scheuner, M. T., Wang, S.-J., Raffel, L. J., Larabell, S. K., & Rotter, J. I. (1997) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19970822)71:3<315::aid-ajmg12>3.0.co;2-n · Cited by 249
Genes, Environment, and Cardiovascular Disease
Sing, C. F., Stengård, J. H., & Kardia, S. L. R. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000075081.51227.86 · Cited by 239
Zhou, X.-P., Marsh, D. J., Morrison, C. D., Chaudhury, A. R., Maxwell, M., Reifenberger, G., & Eng, C. (2003) · The American Journal of Human Genetics · doi:10.1086/379382 · Cited by 229
Self-citationZhou, X.-P., Hampel, H., Thiele, H., Gorlin, R. J., Hennekam, R. C., Parisi, M., Winter, R. M., & Eng, C. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05412-5 · Cited by 225
Self-citationPTEN mutation in a family with Cowden syndrome and autism
Goffin, A., Hoefsloot, L. H., Bosgoed, E., Swillen, A., & Fryns, J. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.1477 · Cited by 213
Lhermitte‐duclos disease and cowden disease: A single phakomatosis
Padberg, G. W., Schot, J. D. L., Vielvoye, G. J., Bots, G. T. A. M., & De Beer, F. C. (1991) · Annals of Neurology · doi:10.1002/ana.410290511 · Cited by 201
Pajukanta, P., Cargill, M., Viitanen, L., Nuotio, I., Kareinen, A., Perola, M., Terwilliger, J. D., Kempas, E., Daly, M., Lilja, H., et al. (2000) · The American Journal of Human Genetics · doi:10.1086/316902 · Cited by 171
Association studies of genetic polymorphisms and complex disease
Gambano, G., Anglani, F., & D’Angelo, A. (2000) · The Lancet · doi:10.1016/s0140-6736(99)07202-5 · Cited by 155
Genome-Wide Linkage Analysis of the Acute Coronary Syndrome Suggests a Locus on Chromosome 2
Harrap, S. B., Zammit, K. S., Wong, Z. Y. H., Williams, F. M., Bahlo, M., Tonkin, A. M., & Anderson, S. T. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000016258.40568.f1 · Cited by 135
McCarthy, J. J., Parker, A., Salem, R., Moliterno, D. J., Wang, Q., Plow, E. F., Rao, S., Shen, G., Rogers, W. J., Newby, L. K., et al. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.016584 · Cited by 134
Germline mutation of the tumour suppressor PTEN in Proteus syndrome
Smith, J. M., Kirk, E. P. E., Theodosopoulos, G., Marshall, G. M., Walker, J., Rogers, M., Field, M., Brereton, J. J., & Marsh, D. J. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.12.937 · Cited by 124
Reardon, W., Zhou, X.-P., & Eng, C. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.12.820 · Cited by 109
Self-citationCowden syndrome and Lhermitte-Duclos disease in a family: a single genetic syndrome with pleiotropy?
Eng, C., Murday, V. A., Seal, S., Mohammed, S. N., Hodgson, S. V., Chaudary, M. A., Fentiman, I. S., Ponder, B. A. J., & Eeles, R. A. (1994) · Journal of Medical Genetics · doi:10.1136/jmg.31.6.458 · Cited by 108
Self-citationThrombospondin-2 Polymorphism Is Associated With a Reduced Risk of Premature Myocardial Infarction
Boekholdt, S. M., Trip, M. D., Peters, R. J. G., Engelen, M., Boer, J. M. A., Feskens, E. J. M., Zwinderman, A. H., Kastelein, J. J. P., & Reitsma, P. H. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000046235.22451.66 · Cited by 67
PTEN hamartoma tumour syndrome: variability of an entity
Merks, J. H. M., de Vries, L. S., Zhou, X.-P., Nikkels, P. G. J., Barth, P. G., Eng, C., & Hennekam, R. C. M. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.10.e111 · Cited by 63
Self-citationCelebi, J. T., Tsou, H. C., Chen, F. F., Zhang, H., Ping, X. L., Lebwohl, M., Kezis, J., & Peacocke, M. (1999) · Journal of Medical Genetics · doi:10.1136/jmg.36.5.360 · Cited by 63
Wessel, J., Topol, E. J., Ji, M. H., Meyer, J. M., & McCarthy, J. J. (2004) · American Heart Journal · doi:10.1016/j.ahj.2003.12.013 · Cited by 59
Delatycki, M. B., Danks, A., Churchyard, A., Zhou, X.-P., & Eng, C. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.8.e92 · Cited by 20
Self-citationAhmed, S., Marsh, D. J., Weremowicz, S., Morton, C. C., Williams, D., & Eng, C. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.12.4665 · Cited by 16
Self-citation
Cited by
Syngal, S., Brand, R. E., Church, J. M., Giardiello, F. M., Hampel, H. L., & Burt, R. W. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.435 · Cited by 1,662
Lifetime Cancer Risks in Individuals with Germline PTEN Mutations
Tan, M.-H., Mester, J. L., Ngeow, J., Rybicki, L. A., Orloff, M. S., & Eng, C. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2283 · Cited by 892
Self-citationGenetic/Familial High-Risk Assessment: Breast and Ovarian
Daly, M. B., Axilbund, J. E., Buys, S., Crawford, B., Farrell, C. D., Friedman, S., Garber, J. E., Goorha, S., Gruber, S. B., Hampel, H., et al. (2010) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2010.0043 · Cited by 646
Self-citationPatel, K. N., Yip, L., Lubitz, C. C., Grubbs, E. G., Miller, B. S., Shen, W., Angelos, P., Chen, H., Doherty, G. M., Fahey, T. J., et al. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000003580 · Cited by 541
Pardo, C. A., & Eberhart, C. G. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00102.x · Cited by 514
Metadata
- Authors
- Pilarski, R., & Eng, C.
- Venue
- Journal of Medical Genetics
- Publisher
- BMJ
- Published
- 2004-04-30
- Volume
- 41
- Issue
- 5
- Pages
- 323-326
- ISSN
- 0022-2593 (ISSN-L)
- 1468-6244
- OpenAlex
- W2002847628
- Cited by
- 329
- References
- 40
- FWCI
- 7.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.